Hesperion Opens Office In Russia

January 2007 | FDI Alert

To exploit the booming clinical trial sector in Eastern Europe, Swiss contract research organisation (CRO) Hesperion has established a full-spectrum facility in Moscow, Russia. BMI sees this development as further confirmation of the emergence of Russia and neighbouring countries as premier locations for clinical studies, given their large patient populations and low-cost bases. We expect other CROs to follow Hesperion's example and increase their presence in the

If you would like to subscribe to Western Europe Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Western Europe Pharma & Healthcare Insight please click on the trial link below.